RENEE LEWIS: Open Payments
NPI 1598377319 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 15 payments from 8 companies in 2025. Trend: 2023 $182 · 2024 $254 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $279 |
| Amgen Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, KRYSTEXXA, UBRELVY, CAPLYTA, Symbravo, MOUNJARO, Rybelsus.
Industry payments across GA — which companies pay providers there.
